Analysis of paired samples from patients with subclonal TP53 alterations, consisting either of a metastatic site or separate sampling of the primary tumor (Fig. 3c), indicated that a TP53 mutation was always carried in both samples and often became clonal in the second specimen. This evidence concerns the gene TP53 and neoplasm.